Not Verified

DoW Prostate Cancer, Early Investigator Research Award

National Institutes of Health

Document Type:	Grants Notice
Funding Opportunity Number:	HT942526PCRPEIRA
Funding Opportunity Title:	DoW Prostate Cancer, Early Investigator Research Award
Opportunity Category:	Discretionary
Opportunity Category Explanation:
Funding Instrument Type:	Grant
Category of Funding Activity:	Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:	14
Assistance Listings:	12.420 -- Military Medical Research and Development
Cost Sharing or Matching Requirement:	No

Version:	Synopsis 1
Posted Date:	May 21, 2026
Last Updated Date:	May 21, 2026
Original Closing Date for Applications:	Sep 02, 2026
Current Closing Date for Applications:	Sep 02, 2026
Archive Date:	Oct 02, 2026
Estimated Total Program Funding:	$ 8,820,000
Award Ceiling:	$
Award Floor:	$

AI Based Application Success Predictor

1. Importance of the research (Significance + Innovation) (Highest Predictor ⭐⭐⭐⭐⭐)

For most NIH Research Project Grants submitted under the current simplified review framework, reviewers first evaluate the importance of the research, combining:

Significance of the scientific problem
Innovation
Potential to advance biomedical knowledge
Potential to improve human health
Addressing important knowledge gaps

Projects that solve important biomedical problems with innovative approaches receive the strongest scores.

2. Scientific rigor and feasibility (Approach) (Highest Predictor ⭐⭐⭐⭐⭐)

The Approach (now incorporated into the Rigor and Feasibility factor for many NIH RPGs) is widely regarded as the single most influential component.

Competitive proposals include:

Strong experimental design
Clearly defined Specific Aims
Appropriate statistical analysis
Rigorous methodology
Reproducibility
Risk mitigation strategies
Realistic milestones
Feasible timeline

Weak methodology is one of the most common reasons for poor NIH scores.

3. High overall scientific impact (Highest Predictor ⭐⭐⭐⭐⭐)

NIH reviewers ultimately assign an Overall Impact Score, reflecting the likelihood that the project will exert a sustained, powerful influence on its field.

Reviewers consider:

Scientific importance
Innovation
Rigor
Feasibility
Investigator expertise
Research environment
Additional review criteria (when applicable)

Applications do not need to be perfect in every category to receive a strong overall impact score.

4. Outstanding investigator(s) and expertise (Very High Predictor ⭐⭐⭐⭐⭐)

Reviewers assess whether the research team has:

Appropriate expertise
Strong publication record
Relevant technical skills
Leadership experience
Ability to complete the proposed work

Under the current framework, investigator expertise contributes to the Expertise and Resources factor.

5. Strong research environment and institutional support (Very High Predictor ⭐⭐⭐⭐⭐)

Competitive applications demonstrate access to:

Appropriate facilities
Core laboratories
Clinical infrastructure
Equipment
Collaborators
Institutional commitment

The research environment should clearly support successful completion of the project.

6. Innovation and originality (Very High Predictor ⭐⭐⭐⭐⭐)

NIH strongly favors projects that:

Challenge existing paradigms
Introduce novel concepts
Develop new methodologies
Create new technologies
Open new areas of investigation

Incremental science is generally less competitive than research with the potential for transformative advances.

7. Alignment with the specific NIH Institute/Center and Funding Opportunity (Very High Predictor ⭐⭐⭐⭐⭐)

Successful applications closely match:

The mission of the assigned NIH Institute or Center
The Notice of Funding Opportunity (NOFO)
Program priorities
Strategic initiatives

Even highly rated applications may not be funded if they do not fit programmatic priorities.

8. Appropriate treatment of additional review criteria (High Predictor ⭐⭐⭐⭐☆)

Depending on the project, reviewers also consider:

Protection of human subjects
Inclusion across the lifespan
Inclusion of women and minorities (where applicable)
Vertebrate animal welfare
Biohazards
Clinical trial timelines

Although these items may not always receive separate numerical scores, deficiencies can negatively affect the overall impact score or funding eligibility.

9. Clear writing and persuasive grantsmanship (High Predictor ⭐⭐⭐⭐☆)

Successful NIH proposals are characterized by:

Clear Specific Aims
Logical organization
Concise writing
Strong scientific rationale
Easy-to-follow figures and diagrams
Consistent narrative

Applications should be understandable to reviewers both within and adjacent to the applicant's field.

10. Realistic budget, project management, and compliance (High Predictor ⭐⭐⭐⭐☆)

Competitive proposals include:

Well-justified budget
Appropriate project scope
Complete documentation
Compliance with NIH policies
Timely submission
Required institutional approvals

Budget requests should align with the scientific objectives and project duration.

Specialties

Cancer

Oncology

Eligibility Requirements

Eligible Applicants:	Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:

Additional Information

Agency Name:

Defense Health Agency Contracting Activity - DHACA

Description:

Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Early Investigator Research Award (EIRA) supports prostate cancer research conducted by investigators in the early stages of their careers with guidance from an experienced mentor. All applications must address one of the FY26 PCRP Overarching Challenges.

Distinctive Features:

· Early-Career Investigator: Serves as the principal investigator. Includes investigators possessing a doctoral degree or equivalent with fewer than three years of postdoctoral research experience at the application submission deadline, excluding clinical residency or clinical fellowship training.

· Mentorship: Applications must include at least one mentor who demonstrates experience in prostate cancer research and successful mentorship.

· Researcher Development Plan: Applications must include a researcher development plan articulating an individualized strategy for acquiring necessary skills, competence, and expertise to complete the project and foster the Principal Investigator’s (PI’s) career development

Eligible Countries:

United States

Sponsor Details

Sponsor Institute/Organizations: National Institutes of Health

Sponsor Type: Government/Federal

Address: 9000 Rockville Pike, Bethesda, MD 20892

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity